(L-R) John Coombe, Finance Director of Glaxo Wellcome, Sir Richard Sykes Chairman of Glaxo Wellcome, Jean-Pierre Garnier Chief Executive Officer elect of Smithkline Beecham and Jan Leschly, Chief Executive of Smithkline Beecham, share a light moment following a news conference on the proposed merger of Glaxo Wellcome and Smithkline Beecham Janaury 17. The two British companies, which tried and failed to merge two years ago, said the deal, worth #114 billion, would give the the scientific and financial clout to be the most efficient drug discovery and marketing machine in the industry.

DJM/PS/ME